Published in J Physiol on July 13, 2006
HCN hyperpolarization-activated cation channels inhibit EPSPs by interactions with M-type K(+) channels. Nat Neurosci (2009) 1.76
Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implications. J Physiol (2008) 1.59
Initial segment Kv2.2 channels mediate a slow delayed rectifier and maintain high frequency action potential firing in medial nucleus of the trapezoid body neurons. J Physiol (2008) 1.46
Rhythm generation through period concatenation in rat somatosensory cortex. PLoS Comput Biol (2008) 1.35
Heteromeric Kv7.2/7.3 channels differentially regulate action potential initiation and conduction in neocortical myelinated axons. J Neurosci (2014) 1.24
Activity-dependent depression of the spike after-depolarization generates long-lasting intrinsic plasticity in hippocampal CA3 pyramidal neurons. J Physiol (2009) 1.20
Homomeric and heteromeric assembly of KCNQ (Kv7) K+ channels assayed by total internal reflection fluorescence/fluorescence resonance energy transfer and patch clamp analysis. J Biol Chem (2008) 1.16
D2-like dopamine receptor-mediated modulation of activity-dependent plasticity at GABAergic synapses in the subthalamic nucleus. J Physiol (2008) 1.16
Beyond faithful conduction: short-term dynamics, neuromodulation, and long-term regulation of spike propagation in the axon. Prog Neurobiol (2011) 1.16
Low expression of Kv7/M channels facilitates intrinsic and network bursting in the developing rat hippocampus. J Physiol (2008) 1.15
Action potential initiation and propagation: upstream influences on neurotransmission. Neuroscience (2008) 1.09
Made for "anchorin": Kv7.2/7.3 (KCNQ2/KCNQ3) channels and the modulation of neuronal excitability in vertebrate axons. Semin Cell Dev Biol (2010) 1.08
P/Q and N channels control baseline and spike-triggered calcium levels in neocortical axons and synaptic boutons. J Neurosci (2010) 1.07
Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration. Transl Stroke Res (2013) 1.06
Antiepileptogenic and antiictogenic effects of retigabine under conditions of rapid kindling: an ontogenic study. Epilepsia (2008) 1.02
M-type potassium channels modulate the intrinsic excitability of infralimbic neurons and regulate fear expression and extinction. J Neurosci (2010) 1.02
Function and mechanism of axonal targeting of voltage-sensitive potassium channels. Prog Neurobiol (2011) 1.01
KCNQ5 channels control resting properties and release probability of a synapse. Nat Neurosci (2011) 1.00
Dorsoventral differences in Kv7/M-current and its impact on resonance, temporal summation and excitability in rat hippocampal pyramidal cells. J Physiol (2015) 1.00
Conditional deletions of epilepsy-associated KCNQ2 and KCNQ3 channels from cerebral cortex cause differential effects on neuronal excitability. J Neurosci (2014) 0.99
New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels. Curr Neurol Neurosci Rep (2008) 0.99
Ion channels in mammalian vestibular afferents may set regularity of firing. J Exp Biol (2008) 0.99
Presynaptic action potential waveform determines cortical synaptic latency. J Physiol (2011) 0.95
A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels. Psychopharmacology (Berl) (2008) 0.92
HCN and KV7 (M-) channels as targets for epilepsy treatment. Neuropharmacology (2012) 0.91
Functional expression of KCNQ (Kv7) channels in guinea pig bladder smooth muscle and their contribution to spontaneous activity. Br J Pharmacol (2013) 0.91
Novel role of KCNQ2/3 channels in regulating neuronal cell viability. Cell Death Differ (2010) 0.89
Central cholinesterase inhibition enhances glutamatergic synaptic transmission. J Neurophysiol (2010) 0.85
Recurrent synapses and circuits in the CA3 region of the hippocampus: an associative network. Front Cell Neurosci (2014) 0.84
Contribution of near-threshold currents to intrinsic oscillatory activity in rat medial entorhinal cortex layer II stellate cells. J Neurophysiol (2012) 0.82
Developmental expression of Kv potassium channels at the axon initial segment of cultured hippocampal neurons. PLoS One (2012) 0.82
Presynaptic inhibitory terminals are functionally abnormal in a rat model of posttraumatic epilepsy. J Neurophysiol (2010) 0.82
Dopamine modulation of Ih improves temporal fidelity of spike propagation in an unmyelinated axon. J Neurosci (2012) 0.82
Complementary functions of SK and Kv7/M potassium channels in excitability control and synaptic integration in rat hippocampal dentate granule cells. J Physiol (2013) 0.81
M-type potassium channels modulate Schaffer collateral-CA1 glutamatergic synaptic transmission. J Physiol (2012) 0.81
D1/D5 modulation of synaptic NMDA receptor currents. J Neurosci (2009) 0.81
Homeostatic regulation of M-current modulates synaptic integration in secretomotor, but not vasomotor, sympathetic neurons in the bullfrog. J Physiol (2010) 0.79
Loss of Local Astrocyte Support Disrupts Action Potential Propagation and Glutamate Release Synchrony from Unmyelinated Hippocampal Axon Terminals In Vitro. J Neurosci (2015) 0.79
Modulation of Kv7 channels and excitability in the brain. Cell Mol Life Sci (2016) 0.78
Electrophysiological events recorded at presynaptic terminals of the crayfish neuromuscular junction with a voltage indicator. J Physiol (2008) 0.78
A unified approach to linking experimental, statistical and computational analysis of spike train data. PLoS One (2014) 0.77
Diverse impact of acute and long-term extracellular proteolytic activity on plasticity of neuronal excitability. Front Cell Neurosci (2015) 0.77
Ethanol Withdrawal Drives Anxiety-Related Behaviors by Reducing M-Type Potassium Channel Activity in the Lateral Habenula. Neuropsychopharmacology (2017) 0.76
Network burst dynamics under heterogeneous cholinergic modulation of neural firing properties and heterogeneous synaptic connectivity. Eur J Neurosci (2016) 0.76
Efficacy of Retigabine on Acute Limbic Seizures in Adult Rats. J Epilepsy Res (2015) 0.76
Bifurcation analysis of a two-compartment hippocampal pyramidal cell model. J Comput Neurosci (2016) 0.75
Nonspecific block of voltage-gated potassium channels has greater effect on distal schaffer collaterals than proximal schaffer collaterals during periods of high activity. Physiol Rep (2017) 0.75
A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (1952) 160.83
K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons. Nature (1997) 7.71
Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature (1980) 7.35
KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science (1998) 7.32
Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res (1982) 5.72
The three-dimensional organization of the hippocampal formation: a review of anatomical data. Neuroscience (1989) 5.58
A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet (1998) 4.89
Active propagation of somatic action potentials into neocortical pyramidal cell dendrites. Nature (1994) 4.87
Action potential repolarization and a fast after-hyperpolarization in rat hippocampal pyramidal cells. J Physiol (1987) 4.43
Excitatory effect of GABAergic axo-axonic cells in cortical microcircuits. Science (2006) 4.39
Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission. Science (1994) 4.38
Activity-dependent action potential invasion and calcium influx into hippocampal CA1 dendrites. Science (1995) 4.29
Intracellular features predicted by extracellular recordings in the hippocampus in vivo. J Neurophysiol (2000) 4.26
A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet (1998) 4.25
The release and uptake of excitatory amino acids. Trends Pharmacol Sci (1990) 3.80
Control of the repetitive discharge of rat CA 1 pyramidal neurones in vitro. J Physiol (1984) 3.71
Modulation of intracortical synaptic potentials by presynaptic somatic membrane potential. Nature (2006) 3.54
Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev (2001) 3.41
Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci (1995) 3.38
Place cells and place recognition maintained by direct entorhinal-hippocampal circuitry. Science (2002) 3.13
Dynamic control of presynaptic Ca(2+) inflow by fast-inactivating K(+) channels in hippocampal mossy fiber boutons. Neuron (2000) 3.07
Characterization of single voltage-gated Na+ and Ca2+ channels in apical dendrites of rat CA1 pyramidal neurons. J Physiol (1995) 2.97
An evaluation of causes for unreliability of synaptic transmission. Proc Natl Acad Sci U S A (1994) 2.90
Different types of calcium channels mediate central synaptic transmission. Nature (1993) 2.86
KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. J Biol Chem (2000) 2.75
The role of BK-type Ca2+-dependent K+ channels in spike broadening during repetitive firing in rat hippocampal pyramidal cells. J Physiol (1999) 2.70
Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat Neurosci (2004) 2.70
Presynaptic action potential amplification by voltage-gated Na+ channels in hippocampal mossy fiber boutons. Neuron (2005) 2.53
Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J Neurosci (2001) 2.52
KCNQ2 is a nodal K+ channel. J Neurosci (2004) 2.49
Presynaptic Ca2+-activated K+ channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release. J Neurosci (2001) 2.48
Two forms of electrical resonance at theta frequencies, generated by M-current, h-current and persistent Na+ current in rat hippocampal pyramidal cells. J Physiol (2002) 2.46
KCNQ/M currents in sensory neurons: significance for pain therapy. J Neurosci (2003) 2.40
Combined analog and action potential coding in hippocampal mossy fibers. Science (2006) 2.39
Association and colocalization of the Kvbeta1 and Kvbeta2 beta-subunits with Kv1 alpha-subunits in mammalian brain K+ channel complexes. J Neurosci (1997) 2.34
Modulation of transmitter release by presynaptic resting potential and background calcium levels. Neuron (2005) 2.27
Presynaptic ionotropic receptors and the control of transmitter release. Annu Rev Neurosci (1999) 2.24
KCNQ/M channels control spike afterdepolarization and burst generation in hippocampal neurons. J Neurosci (2004) 2.20
Information processing in the axon. Nat Rev Neurosci (2004) 2.19
Afterpotential generation in hippocampal pyramidal cells. J Neurophysiol (1981) 2.14
An after-hyperpolarization of medium duration in rat hippocampal pyramidal cells. J Physiol (1989) 2.08
Delayed K+ clearance associated with aquaporin-4 mislocalization: phenotypic defects in brains of alpha-syntrophin-null mice. Proc Natl Acad Sci U S A (2003) 2.06
Presynaptic facilitation revisited: state and time dependence. J Neurosci (1996) 2.04
Kv7/KCNQ/M and HCN/h, but not KCa2/SK channels, contribute to the somatic medium after-hyperpolarization and excitability control in CA1 hippocampal pyramidal cells. J Physiol (2005) 2.00
M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain. J Neurosci (2001) 1.94
Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol (2000) 1.93
Presynaptic A-current based on heteromultimeric K+ channels detected in vivo. Nature (1993) 1.90
Potassium conductances in hippocampal neurons blocked by excitatory amino-acid transmitters. Nature (1990) 1.77
Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol (2000) 1.76
Presynaptic, extrasynaptic and axonal GABAA receptors in the CNS: where and why? Prog Biophys Mol Biol (2005) 1.74
Presynaptic K+ channels: electrifying regulators of synaptic terminal excitability. Trends Neurosci (2004) 1.71
Presynaptic kainate receptor mediation of frequency facilitation at hippocampal mossy fiber synapses. Science (2001) 1.71
The sodium current underlying action potentials in guinea pig hippocampal CA1 neurons. J Gen Physiol (1988) 1.71
Molecular correlates of the M-current in cultured rat hippocampal neurons. J Physiol (2002) 1.68
M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals. J Neurosci (2004) 1.66
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res (1996) 1.61
Action potentials reliably invade axonal arbors of rat neocortical neurons. Proc Natl Acad Sci U S A (2000) 1.59
Dendritic Ih normalizes temporal summation in hippocampal CA1 neurons Nat Neurosci (1999) 1.59
Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc Natl Acad Sci U S A (2001) 1.57
Functional characteristics of unmyelinated fibres in the hippocampal cortex. Brain Res (1978) 1.54
Feedforward excitation of the hippocampus by afferents from the entorhinal cortex: redefinition of the role of the trisynaptic pathway. Proc Natl Acad Sci U S A (1990) 1.48
Cell type-specific dependence of muscarinic signalling in mouse hippocampal stratum oriens interneurones. J Physiol (2005) 1.47
Ion regulation in the brain: implications for pathophysiology. Neuroscientist (2002) 1.47
Effects of a cognition-enhancer, linopirdine (DuP 996), on M-type potassium currents (IK(M)) and some other voltage- and ligand-gated membrane currents in rat sympathetic neurons. Eur J Neurosci (1997) 1.45
GABAA receptors at hippocampal mossy fibers. Neuron (2003) 1.41
Presynaptic localization of Kv1.4-containing A-type potassium channels near excitatory synapses in the hippocampus. J Neurosci (1998) 1.40
Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine. J Pharmacol Exp Ther (1998) 1.39
Timing and efficacy of Ca2+ channel activation in hippocampal mossy fiber boutons. J Neurosci (2002) 1.38
Contrasting effects of the persistent Na+ current on neuronal excitability and spike timing. Neuron (2006) 1.38
Experimental localization of Kv1 family voltage-gated K+ channel alpha and beta subunits in rat hippocampal formation. J Neurosci (2001) 1.33
Single-axon action potentials in the rat hippocampal cortex. J Physiol (2003) 1.30
Regenerative properties of pyramidal cell dendrites in area CA1 of the rat hippocampus. J Physiol (1995) 1.29
Activity-evoked increases in extracellular potassium modulate presynaptic excitability in the CA1 region of the hippocampus. J Neurophysiol (1987) 1.29
Calcium-activated potassium conductances contribute to action potential repolarization at the soma but not the dendrites of hippocampal CA1 pyramidal neurons. J Neurosci (1999) 1.28
Entorhinal projections to the hippocampal CA1 region in the rat: an underestimated pathway. Neurosci Lett (1988) 1.24
Selective effects of potassium elevations on glutamate signaling and action potential conduction in hippocampus. J Neurosci (2004) 1.17
Properties of single voltage-dependent K+ channels in dendrites of CA1 pyramidal neurones of rat hippocampus. J Physiol (2004) 1.16
D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. Eur J Pharmacol (1996) 1.11
Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission. Mol Pharmacol (2002) 1.11
Phosphorylation-dependent differences in the activation properties of distal and proximal dendritic Na+ channels in rat CA1 hippocampal neurons. J Physiol (2002) 1.07
Activity-dependent excitability changes in hippocampal CA3 cell Schaffer axons. J Physiol (2004) 1.07
Shunting versus inactivation: analysis of presynaptic inhibitory mechanisms in primary afferents of the crayfish. J Neurosci (1999) 1.05
High safety factor for action potential conduction along axons but not dendrites of cultured hippocampal and cortical neurons. J Neurophysiol (1998) 1.04
Somatostatin augments the M-current in hippocampal neurons. Science (1988) 1.04
Investigations into the mechanism of action of the new anticonvulsant retigabine. Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels. Arzneimittelforschung (2000) 1.04
General and variable features of varicosity spacing along unmyelinated axons in the hippocampus and cerebellum. Proc Natl Acad Sci U S A (2002) 1.01
A simulation of action potentials in synaptic boutons during presynaptic inhibition. J Neurophysiol (1994) 1.00
Molecular identification of SqKv1A. A candidate for the delayed rectifier K channel in squid giant axon. J Gen Physiol (1996) 0.96
Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation. Neuroscience (2003) 0.96
Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus. J Neurophysiol (1997) 0.96
Stimulation-evoked changes in extracellular K+ and Ca2+ in pyramidal layers of the rat's hippocampus. Can J Physiol Pharmacol (1982) 0.95
Solution structure and function of the "tandem inactivation domain" of the neuronal A-type potassium channel Kv1.4. J Biol Chem (2003) 0.95
Changes in extracellular Ca2+ and K+ activity accompanying hippocampal discharges. Can J Physiol Pharmacol (1980) 0.93
Backpropagation of action potentials generated at ectopic axonal loci: hypothesis that axon terminals integrate local environmental signals. Brain Res Brain Res Rev (1995) 0.93
The therapeutic potential of neuronal KCNQ channel modulators. Expert Opin Ther Targets (2003) 0.92
Interaction between synaptic excitation and slow afterhyperpolarization current in rat hippocampal pyramidal cells. J Physiol (2001) 0.90
Hippocampal excitability and changes in extracellular potassium. Exp Neurol (1981) 0.88
Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro. J Neurosci (1994) 0.86
Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response. Neurosci Lett (1995) 0.85
Increased excitability of hippocampal unmyelinated fibres following conditioning stimulation. Brain Res (1981) 0.84
Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol (1994) 5.61
Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med (1998) 4.51
Class II-independent generation of CD4 memory T cells from effectors. Science (1999) 3.96
Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency. Proc Natl Acad Sci U S A (2004) 2.97
The role of BK-type Ca2+-dependent K+ channels in spike broadening during repetitive firing in rat hippocampal pyramidal cells. J Physiol (1999) 2.70
Detection of Chlamydia trachomatis infection in urine samples from men and women by ligase chain reaction. J Clin Microbiol (1995) 2.50
Presynaptic Ca2+-activated K+ channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release. J Neurosci (2001) 2.48
Chemistry of single-walled carbon nanotubes. Acc Chem Res (2002) 2.10
Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. J Intern Med (2014) 2.06
PKA mediates the effects of monoamine transmitters on the K+ current underlying the slow spike frequency adaptation in hippocampal neurons. Neuron (1993) 2.04
Decrease in birth weight in relation to maternal bone-lead burden. Pediatrics (1997) 2.00
Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. Am J Epidemiol (2001) 1.97
The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized rats. Bone (2004) 1.84
Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J Virol (1998) 1.72
The effectiveness of housing policies in reducing children's lead exposure. Am J Public Health (2001) 1.70
K x-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys Med Biol (1995) 1.70
Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney Int (2007) 1.66
A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women. Breast Cancer Res Treat (2009) 1.63
Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health (1994) 1.60
Plexin-B semaphorin receptors interact directly with active Rac and regulate the actin cytoskeleton by activating Rho. Curr Biol (2001) 1.59
The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J Neurosci (1998) 1.58
A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. JAMA (1996) 1.57
Improvements in the calibration of 109Cd K x-ray fluorescence systems for measuring bone lead in vivo. Phys Med Biol (1994) 1.54
Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults. Heart (2006) 1.53
Low-level lead exposure and renal function in the Normative Aging Study. Am J Epidemiol (1994) 1.51
Reduced K+ channel inactivation, spike broadening, and after-hyperpolarization in Kvbeta1.1-deficient mice with impaired learning. Learn Mem (1999) 1.51
Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol (1998) 1.50
Dietary and environmental determinants of blood and bone lead levels in lactating postpartum women living in Mexico City. Environ Health Perspect (1996) 1.48
Association analysis between mood disorder and monoamine oxidase gene. Am J Med Genet (2000) 1.48
Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci U S A (1999) 1.46
Correlates of fitness for duty in hazardous materials firefighters. Am J Ind Med (1999) 1.44
Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Arch Intern Med (1998) 1.38
Fitness for duty evaluations in hazardous materials firefighters. J Occup Environ Med (1998) 1.38
A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect (1995) 1.37
Fragmented condensate ground state of trapped weakly interacting bosons in two dimensions. Phys Rev Lett (2001) 1.36
IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells. Clin Exp Allergy (2008) 1.36
Arsenic in drinking water and incidence of urinary cancers. Epidemiology (1997) 1.35
Functional and molecular aspects of voltage-gated K+ channel beta subunits. Ann N Y Acad Sci (1999) 1.34
Automated bone lead analysis by K-x-ray fluorescence for the clinical environment. Basic Life Sci (1990) 1.34
MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ (2011) 1.33
Age and secular trends in bone lead levels in middle-aged and elderly men: three-year longitudinal follow-up in the Normative Aging Study. Am J Epidemiol (1997) 1.33
Lead and hypertension in a sample of middle-aged women. Am J Public Health (1999) 1.32
Lead toxicity in older adults. J Am Geriatr Soc (2000) 1.31
Reactive airways dysfunction after exposure to teargas. Lancet (1992) 1.30
FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation (1997) 1.26
Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein. J Gene Med (2000) 1.23
Interrelations of lead levels in bone, venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women. Environ Health Perspect (2001) 1.22
Protein kinase A-independent modulation of ion channels in the brain by cyclic AMP. Proc Natl Acad Sci U S A (1995) 1.20
Relation of nutrition to bone lead and blood lead levels in middle-aged to elderly men. The Normative Aging Study. Am J Epidemiol (1998) 1.20
Tumor-initiating and promoting activities of di(2-ethylhexyl) phthalate in vivo and in vitro. Environ Health Perspect (1986) 1.19
Electrocardiographic conduction disturbances in association with low-level lead exposure (the Normative Aging Study). Am J Cardiol (1998) 1.19
Specificity of protein kinase inhibitor peptides and induction of long-term potentiation. Proc Natl Acad Sci U S A (1994) 1.18
Relations between individual and neighborhood-based measures of socioeconomic position and bone lead concentrations among community-exposed men: the Normative Aging Study. Am J Epidemiol (1999) 1.17
Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer. Clin Transl Oncol (2012) 1.16
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc Natl Acad Sci U S A (1998) 1.15
The influence of bone and blood lead on plasma lead levels in environmentally exposed adults. Environ Health Perspect (1998) 1.15
Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology (2009) 1.14
Long-term efficacy after [E1-, polymerase-] adenovirus-mediated transfer of human acid-alpha-glucosidase gene into glycogen storage disease type II knockout mice. Hum Gene Ther (2001) 1.14
Analysis of chromosomal and organellar DNA of somatic hybrids between Triticum aestiuvm and Haynaldia villosa Schur. Mol Genet Genomics (2001) 1.13
A broad role for the zinc finger protein ZNF202 in human lipid metabolism. J Biol Chem (2000) 1.13
Protein kinase A mediates the modulation of the slow Ca(2+)-dependent K(+) current, I(sAHP), by the neuropeptides CRF, VIP, and CGRP in hippocampal pyramidal neurons. J Neurophysiol (2000) 1.13
Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis (2005) 1.13
Location-specific, unequal contribution of the N glycans in simian immunodeficiency virus gp120 to viral infectivity and removal of multiple glycans without disturbing infectivity. J Virol (1998) 1.09
A longitudinal study of chronic lead exposure and physical growth in Boston children. Environ Health Perspect (1995) 1.08
Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153. Neoplasma (2011) 1.08
BK channel activity determines the extent of cell degeneration after oxygen and glucose deprivation: a study in organotypical hippocampal slice cultures. Neuroscience (2002) 1.06
Residual cognitive deficits 50 years after lead poisoning during childhood. Br J Ind Med (1993) 1.06
Measurements of pertinent concentrations of oxygen in vivo. Magn Reson Med (1991) 1.06
A case control and family based association study of the neuregulin1 gene and schizophrenia. J Med Genet (2004) 1.05
Lead poisoning from mobilization of bone stores during thyrotoxicosis. Am J Ind Med (1994) 1.05
Arsenic in drinking water and skin cancers: cell-type specificity (Taiwan, ROC). Cancer Causes Control (2001) 1.05
Dopamine modulates the slow Ca(2+)-activated K+ current IAHP via cyclic AMP-dependent protein kinase in hippocampal neurons. J Neurophysiol (1995) 1.05
Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study. J Rheumatol (2000) 1.04
Modulation of the Ca2+-activated K+ current sIAHP by a phosphatase-kinase balance under basal conditions in rat CA1 pyramidal neurons. J Neurophysiol (1998) 1.04
Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol (2000) 1.02
Vibration perception thresholds in workers with long term exposure to lead. Occup Environ Med (2000) 1.02
Effect of maternal lead burden on infant weight and weight gain at one month of age among breastfed infants. Pediatrics (2001) 1.02
Stability of hydrophilic magnetic nanoparticles under biologically relevant conditions. J Nanosci Nanotechnol (2008) 1.01
Preparation of All-Trans Retinoic Acid nanosuspensions using a modified precipitation method. Drug Dev Ind Pharm (2006) 1.01
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women. Breast Cancer Res Treat (2011) 1.00
Effects of proteins from culture medium on surface property of silanes- functionalized magnetic nanoparticles. Nanoscale Res Lett (2008) 1.00
Relationship of blood lead levels to personal hygiene habits in lead battery workers: Taiwan, 1991-1997. Am J Ind Med (1999) 1.00
Influence of bone resorption on the mobilization of lead from bone among middle-aged and elderly men: the Normative Aging Study. Environ Health Perspect (2001) 0.99
Validation of K-XRF bone lead measurement in young adults. Environ Health Perspect (1995) 0.98
Modeling vaccination campaigns and the Fall/Winter 2009 activity of the new A(H1N1) influenza in the Northern Hemisphere. Emerg Health Threats J (2009) 0.98
Validation of K x-ray fluorescence bone lead measurements by inductively coupled plasma mass spectrometry in cadaver legs. Med Phys (2000) 0.98
Prostate-specific antigen expression by various tumors. J Clin Lab Anal (1995) 0.98
Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months. Mol Cell Biochem (2000) 0.97
A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages. Hum Pathol (2001) 0.95
A case-control study of oral cancer in Beijing, People's Republic of China. Associations with nutrient intakes, foods and food groups. Eur J Cancer B Oral Oncol (1993) 0.95
Determinants of bone and blood lead concentrations in the early postpartum period. Occup Environ Med (2000) 0.95
Long-term health and employment outcomes of occupational asthma and their determinants. J Occup Environ Med (1998) 0.95
Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue. Diabet Med (2011) 0.94
Differential enhancement of gamma-glutamyl transpeptidase and gamma-glutamylcysteine synthetase by tert-butylhydroquinone in rat lung epithelial L2 cells. Am J Respir Cell Mol Biol (1996) 0.94
Correlates of bone and blood lead levels in carpenters. Am J Ind Med (1994) 0.94
An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood. J Biol Chem (1995) 0.94
Using ecological data to estimate a regression model for individual data: the association between arsenic in drinking water and incidence of skin cancer. Environ Res (1998) 0.93
Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase. J Thromb Haemost (2010) 0.93